This topic contains a solution. Click here to go to the answer

Author Question: Which range represents the therapeutic INR range for a patient taking Coumadin? a. 1.0 to 2.0 b. ... (Read 33 times)

newbem

  • Hero Member
  • *****
  • Posts: 579
Which range represents the therapeutic INR range for a patient taking Coumadin?
 
  a. 1.0 to 2.0
  b. 2.0 to 3.0
  c. 3.0 to 4.0
  d. 4.0 to 5.0

Question 2

A patient is taking insulin each morning. When the insulin peaks, the patient should be observed for which signs of hypoglycemia?
 
  a. Nervousness, hunger, weakness, pallor, and confusion
  b. Tachycardia and acetone breath
  c. Tachycardia, loss of consciousness, and Kussmaul respirations
  d. Serum glucose greater than 150 mg/dL, hunger, and confusion



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Leostella20

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

ANS: B
The specific INR goal recommendations for each clinical indication is typically 2.0 to 3.0, except in cases of cardiac valve replacement, for which it is higher.

Answer to Question 2

ANS: A
Hypoglycemia is serum glucose of less than 60 mg/dL, which is caused by taking too much insulin. Symptoms include nervousness; hunger; weakness; cold, clammy skin; and change in the level of consciousness.





 

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

For a complete list of videos, visit our video library